Controlled trial with human lymphoblastoid interferon among HBeAg and anti-HBe-positive chronic hepatitis B patients in Egypt.

MLA

El-Zayadi, A., et al. “Controlled Trial with Human Lymphoblastoid Interferon among HBeAg and Anti-HBe-Positive Chronic Hepatitis B Patients in Egypt.” The Journal of the Egyptian Public Health Association, vol. 70, no. 5–6, 1995, pp. 579–94. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17214176&authtype=sso&custid=ns315887.

APA

El-Zayadi, A., Osaima, S., Haseeb, N., & Dabbous, H. (1995). Controlled trial with human lymphoblastoid interferon among HBeAg and anti-HBe-positive chronic hepatitis B patients in Egypt. The Journal of the Egyptian Public Health Association, 70(5–6), 579–594.

Chicago

El-Zayadi, A, S Osaima, N Haseeb, and H Dabbous. 1995. “Controlled Trial with Human Lymphoblastoid Interferon among HBeAg and Anti-HBe-Positive Chronic Hepatitis B Patients in Egypt.” The Journal of the Egyptian Public Health Association 70 (5–6): 579–94. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17214176&authtype=sso&custid=ns315887.